Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P4
Near historical low
vs 5Y Ago
-2.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.15% |
| Q3 2025 | -10.77% |
| Q2 2025 | -14.63% |
| Q1 2025 | -29.20% |
| Q4 2024 | 104.43% |
| Q3 2024 | 18.61% |
| Q2 2024 | 1.35% |
| Q1 2024 | 3.12% |
| Q4 2023 | 4.31% |
| Q3 2023 | 3.21% |
| Q2 2023 | 23.68% |
| Q1 2023 | 15.30% |
| Q4 2022 | 1.80% |
| Q3 2022 | -8.07% |
| Q2 2022 | 0.59% |
| Q1 2022 | 9.75% |
| Q4 2021 | 22.38% |
| Q3 2021 | 13.25% |
| Q2 2021 | 55.02% |
| Q1 2021 | 18.00% |
| Q4 2020 | 8.76% |
| Q3 2020 | 34.99% |
| Q2 2020 | -7.23% |
| Q1 2020 | 0.00% |